202 related articles for article (PubMed ID: 33412493)
1. DZ2002 alleviates psoriasis-like skin lesions via differentially regulating methylation of GATA3 and LCN2 promoters.
Chen L; Lin Z; Liu Y; Cao S; Huang Y; Yang X; Zhu F; Tang W; He S; Zuo J
Int Immunopharmacol; 2021 Feb; 91():107334. PubMed ID: 33412493
[TBL] [Abstract][Full Text] [Related]
2. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
[TBL] [Abstract][Full Text] [Related]
3. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4.
Rácz E; Kurek D; Kant M; Baerveldt EM; Florencia E; Mourits S; de Ridder D; Laman JD; van der Fits L; Prens EP
PLoS One; 2011; 6(5):e19806. PubMed ID: 21611195
[TBL] [Abstract][Full Text] [Related]
4. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.
Meng Q; Liu Y; Yao L; Ma Z; Guo L; Hu T; Luo Y; Chen J; Dang E; Li Z
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):145-156. PubMed ID: 37669859
[TBL] [Abstract][Full Text] [Related]
5. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
6. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models.
Zhang Z; Wu Y; Wu B; Qi Q; Li H; Lu H; Fan C; Feng C; Zuo J; Niu L; Tang W
Arthritis Res Ther; 2019 Dec; 21(1):290. PubMed ID: 31842999
[TBL] [Abstract][Full Text] [Related]
7. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
[TBL] [Abstract][Full Text] [Related]
9. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
10. Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion.
Shao S; Cao T; Jin L; Li B; Fang H; Zhang J; Zhang Y; Hu J; Wang G
J Invest Dermatol; 2016 Jul; 136(7):1418-1428. PubMed ID: 26979478
[TBL] [Abstract][Full Text] [Related]
11. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.
He SJ; Lin ZM; Wu YW; Bai BX; Yang XQ; He PL; Zhu FH; Tang W; Zuo JP
Acta Pharmacol Sin; 2014 Feb; 35(2):219-29. PubMed ID: 24374810
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.
Thatikonda S; Pooladanda V; Sigalapalli DK; Godugu C
Cell Death Dis; 2020 Jan; 11(1):21. PubMed ID: 31924750
[TBL] [Abstract][Full Text] [Related]
15. Albendazole negatively regulates keratinocyte proliferation.
Di Fusco D; Stolfi C; Di Grazia A; Dinallo V; Laudisi F; Marafini I; Colantoni A; Monteleone I; Monteleone G
Clin Sci (Lond); 2020 Apr; 134(7):907-920. PubMed ID: 32236445
[TBL] [Abstract][Full Text] [Related]
16. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
17. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
18. Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB/c mice by inhibiting the MAPK signaling pathway.
Long Q; Ma T; Wang Y; Chen S; Tang S; Wang T; Zhou Y; Xu K; Wan P; Cao Y
Int Immunopharmacol; 2024 Jun; 134():112261. PubMed ID: 38761783
[TBL] [Abstract][Full Text] [Related]
19. The miR-155/GATA3/IL37 axis modulates the production of proinflammatory cytokines upon TNF-α stimulation to affect psoriasis development.
Wang H; Zhang Y; Luomei J; Huang P; Zhou R; Peng Y
Exp Dermatol; 2020 Jul; 29(7):647-658. PubMed ID: 32472715
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation.
Li H; Zhang C; Bian L; Deng H; Blevins M; Han G; Fan B; Yang C; Zhao R; High W; Norris D; Fujita M; Wang XJ; Huang M
J Invest Dermatol; 2022 Feb; 142(2):390-401. PubMed ID: 34293351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
